| Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and … SD Banister, M Longworth, R Kevin, S Sachdev, M Santiago, J Stuart, ... ACS Chemical Neuroscience 7 (9), 1241-1254, 2016 | 252 | 2016 |
| Absence of Entourage: Terpenoids Commonly Found in Cannabis sativa Do Not Modulate the Functional Activity of Δ9-THC at Human CB1 and CB2 Receptors M Santiago, S Sachdev, JC Arnold, IS McGregor, M Connor Cannabis and cannabinoid research 4 (3), 165-176, 2019 | 112 | 2019 |
| Cannabichromene is a cannabinoid CB2 receptor agonist M Udoh, M Santiago, S Devenish, IS McGregor, M Connor British Journal of Pharmacology 176 (23), 4537-4547, 2019 | 91 | 2019 |
| A continuous, fluorescence-based assay of µ-opioid receptor activation in AtT-20 cells A Knapman, M Santiago, YP Du, PR Bennallack, MJ Christie, M Connor Journal of biomolecular screening 18 (3), 269-276, 2013 | 63 | 2013 |
| In vitro determination of the efficacy of illicit synthetic cannabinoids at CB1 receptors S Sachdev, K Vemuri, SD Banister, M Longworth, M Kassiou, M Santiago, ... British Journal of Pharmacology 176 (24), 4653-4665, 2019 | 45 | 2019 |
| Buprenorphine signalling is compromised at the N40D polymorphism of the human μ opioid receptor in vitro A Knapman, M Santiago, M Connor British journal of pharmacology 171 (18), 4273-4288, 2014 | 24 | 2014 |
| Development of bright and biocompatible nanoruby and its application to background-free time-gated imaging of G-protein-coupled receptors VKA Sreenivasan, WA Wan Razali, K Zhang, RR Pillai, A Saini, ... ACS applied materials & interfaces 9 (45), 39197-39208, 2017 | 17 | 2017 |
| A6V polymorphism of the human μ‐opioid receptor decreases signalling of morphine and endogenous opioids in vitro A Knapman, M Santiago, M Connor British Journal of Pharmacology 172 (9), 2258-2272, 2015 | 15 | 2015 |
Mark ConnorProfessor of Pharmacology, Macquarie UniversityVerified email at mq.edu.au
